載入...
Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study
BACKGROUND: TNF inhibitors have been used as a treatment for moderate to severe RA patients. However, reliable biomarkers that predict therapeutic response to TNF inhibitors are lacking. In this study, we investigated whether chemokines may represent useful biomarkers to predict the response to TNF...
Na minha lista:
| 發表在: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840903/ https://ncbi.nlm.nih.gov/pubmed/27102921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0995-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|